AbCellera Biologics, Inc. (ABCL)
3.49
+0.21
(+6.40%)
USD |
NASDAQ |
Mar 31, 16:00
3.55
+0.06
(+1.72%)
Pre-Market: 08:06
AbCellera Biologics Shareholders Equity (Quarterly) : 966.90M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | 21.52M |
| Oncolytics Biotech, Inc. | -2.772M |
| Aurinia Pharmaceuticals, Inc. | 581.33M |
| Edesa Biotech, Inc. | 13.95M |
| Lexaria Bioscience Corp. | 4.913M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.357B |
| Total Liabilities (Quarterly) | 215.59M |
| Debt to Equity Ratio | 0.1481 |
| Current Ratio | 11.32 |
| Net Debt Paydown Yield | -1.40% |